CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 44 enrolled
Drug / intervention
0.75% Ropivacaine +3 moredrug
Likely dose
0.75% Ropivacaine 20 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02270255
NCT02270255Phase 2Completed
CompareCT.gov

Prospective Blinded Study Looking at PO/IV Analgesia Alone Versus PO/IV Analgesia With Superior Hypogastric Nerve Block for Uterine Artery Embolization Pain Management

McGill University Health Centre/Research Institute of the McGill University Health Centre·interventional·Posted Oct 21, 2014·Updated Aug 14, 2019

In Brief

A Phase 2 clinical trial evaluating Superior hypogastric nerve block, 0.75% Ropivacaine, and 2 other interventions for Leiomyoma. Completed, enrolled 44 participants across 1 site.

Detailed Summary

Uterine fibroid embolization (UFE) is now an accepted treatment of uterine fibroids. However the procedure is often very painful and, in many centres, patients are admitted overnight with patient controlled analgesic (PCA) pumps for pain control and discharged the next day with heavy pain medications. The goal of this study is to evaluate the effectiveness of a superior hypogastric nerve block (SHGNB) in controlling the pain post-UFE.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeiomyoma
CountriesCanada
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 21, 2014
Enrollment StartApr 1, 2015
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.7 years ago

Interventions

Superior hypogastric nerve blockprocedure

21g Chiba needle advanced into the superior hypogastric plexus via an anterior infraumbilical approach using the arterial catheter as a fluoroscopic landmark to target the vertebral body below.

0.75% Ropivacainedrug

20 ml of 0.75% Ropivacaine

Subcutaneous injectionprocedure

Injection into subcutaneous tissues in periumbilical region

1% Xylocainedrug

5ml of 1% Xylocaine